Regeneron, US75886F1075

Regeneron stock pre-market: EUR 659.95, plus 0.05 percent

Published on 10/09/2026 at 08:24 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Regeneron stock was at EUR 659.95 pre-market at Lang & Schwarz on October 9, 2026, up 0.05 percent. The next scheduled results date is October 30.

Key points in brief

  • Regeneron traded at EUR 659.95 pre-market on October 9, 2026.
  • The stock was up 0.05 percent versus the EUR 659.65 prior close.
  • Third-quarter results are scheduled for October 30, 2026.],
  • Tags
Isometrische 3D-Illustration einer Bioreaktor- und Zellkultur-Prozesskette in Pastellfarben
Regeneron Pharma US75886F1075 stellt ein isometrisches 3D-Diagramm der Bioreaktor-Wertschöpfungskette samt Zellkultur und Aufreinigung dar, Illustration mit AI erstellt.

Regeneron stock was at EUR 659.95 pre-market at Lang & Schwarz at 8:23 a.m. CEST on October 9, 2026, up 0.05 percent versus the EUR 659.65 prior close from October 8, 2026.

Pre-market trading

Lang & Schwarz showed a bid of EUR 657.10 and an ask of EUR 662.80. The further course from the Xetra open at 9:00 a.m. CEST is shown by the continuously updated real-time quote of Regeneron stock.

What matters today

Regeneron’s next scheduled financial update is October 30, 2026, before the U.S. financial markets open, with the conference call at 8:30 a.m. Eastern Time. A round-number level of EUR 700.00 is 6.07 percent above the pre-market price. The finance-data P/E ratio was 18.29 as of October 9, 2026.

Next quarterly update

Regeneron Pharmaceuticals announced that it will report third-quarter 2026 financial and operating results on October 30, 2026, before the U.S. financial markets open. The company said it will host a conference call and webcast at 8:30 a.m. Eastern Time that day.

Market context: Market report Nasdaq Composite.

More news and analysis on Regeneron stock

Disclaimer...

en | US75886F1075 | REGENERON | boerse | 70273237 | bgmi